These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9753218)

  • 41. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia.
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Brain Res; 1999 Jan; 816(2):471-9. PubMed ID: 9878871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons.
    Andrus PK; Fleck TJ; Oostveen JA; Hall ED
    J Neurosci Res; 1997 Mar; 47(6):650-4. PubMed ID: 9089214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro.
    Othberg A; Keep M; Brundin P; Lindvall O
    Exp Neurol; 1997 Oct; 147(2):498-502. PubMed ID: 9344573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
    Hall ED; Yonkers PA; Horan KL; Braughler JM
    J Neurotrauma; 1989; 6(3):169-76. PubMed ID: 2810381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury.
    Kupina NC; Nath R; Bernath EE; Inoue J; Mitsuyoshi A; Yuen PW; Wang KK; Hall ED
    J Neurotrauma; 2001 Nov; 18(11):1229-40. PubMed ID: 11721741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
    Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
    Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury.
    Liu C; Lin N; Wu B; Qiu Y
    Brain Res; 2009 Jul; 1282():173-82. PubMed ID: 19501064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP.
    Pandya JD; Pauly JR; Sullivan PG
    Exp Neurol; 2009 Aug; 218(2):381-9. PubMed ID: 19477175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F).
    Althaus JS; Andrus PK; Williams CM; VonVoigtlander PF; Cazers AR; Hall ED
    Mol Chem Neuropathol; 1993 Oct; 20(2):147-62. PubMed ID: 8297419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
    Svedin P; Guan J; Mathai S; Zhang R; Wang X; Gustavsson M; Hagberg H; Mallard C
    Dev Neurosci; 2007; 29(4-5):393-402. PubMed ID: 17762207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents.
    Pandya JD; Pauly JR; Nukala VN; Sebastian AH; Day KM; Korde AS; Maragos WF; Hall ED; Sullivan PG
    J Neurotrauma; 2007 May; 24(5):798-811. PubMed ID: 17518535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia.
    Park CK; Hall ED
    Brain Res; 1994 May; 645(1-2):157-63. PubMed ID: 8062078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid peroxidation and oedema in experimental brain injury: comparison of treatment with methylprednisolone, tirilazad mesylate and vitamin E.
    Koç RK; Kurtsoy A; Paşaoğlu H; Karaküçük EI; Oktem IS; Meral M
    Res Exp Med (Berl); 1999 Jul; 199(1):21-8. PubMed ID: 10494671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain.
    Coderre TJ; Kumar N; Lefebvre CD; Yu JS
    J Neurochem; 2007 Mar; 100(5):1289-99. PubMed ID: 17241130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage.
    Hall ED
    Eur J Anaesthesiol; 1996 May; 13(3):279-89. PubMed ID: 8737119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Grape seed extract suppresses lipid peroxidation and reduces hypoxic ischemic brain injury in neonatal rats.
    Feng Y; Liu YM; Fratkins JD; LeBlanc MH
    Brain Res Bull; 2005 Jul; 66(2):120-7. PubMed ID: 15982528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor.
    Jang YP; Kim SR; Choi YH; Kim J; Kim SG; Markelonis GJ; Oh TH; Kim YC
    J Neurosci Res; 2002 Apr; 68(2):233-40. PubMed ID: 11948668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Edaravone inhibits lipid peroxidation in neonatal hypoxic-ischemic rats: an in vivo microdialysis study.
    Noor JI; Ueda Y; Ikeda T; Ikenoue T
    Neurosci Lett; 2007 Feb; 414(1):5-9. PubMed ID: 17280782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
    Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
    J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole.
    Banasr M; Chowdhury GM; Terwilliger R; Newton SS; Duman RS; Behar KL; Sanacora G
    Mol Psychiatry; 2010 May; 15(5):501-11. PubMed ID: 18825147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.